tert-Butyl piperazine-1-carboxylate → N-(4-methoxy-3-piperazin-1-yl-phenyl)-acetamide

HRID 521

Reaction equation

HRID 521 reaction equation
CC(C)(C)OC(=O)N1CCNCC1.COc1ccc(NC(C)=O)cc1Br>CC(=O)O.CC(=O)O.CC(C)(C)[O-].CC(C)Oc1cccc(OC(C)C)c1-c1ccccc1P(C1CCCCC1)C1CCCCC1.Cc1ccccc1.[Na+].[Pd]>COc1ccc(NC(C)=O)cc1N1CCNCC1

Participants

7

Conditions

Temperature
100 °C

Procedure

A solution of N-(3-bromo-4-methoxyphenyl)acetamide (0.5 g, 2.05 mmol) dissolved in toluene (5 mL) was treated with tert-butyl piperazine-1-carboxylate (0.382 g, 2.05 mmol), diacetoxypalladium (0.046 g, 0.20 mmol), dicyclohexyl(2',6'-diisopropoxybiphenyl-2-yl)phosphine (0.191 g, 0.41 mmol) and sodium 2-methylpropan-2-olate (0.433 g, 4.51 mmol) in a sealed tube. The resulting mixture was degassed and stirred at 100 °C for 8 hours in a microwave. The mixture was pre-absorbed onto silica. The crude product was purified by flash silica chromatography, elution 50% ethyl acetate in Heptane. Pure fractions were evaporated to dryness to afford intermediate. The intermediate was dissolved in 4M HCl in dioxane (10mL) and stirred at RT overnight. The mixture was evaporated to give N-(4-methoxy-3-(piperazin-1-yl)phenyl)acetamide (0.260 g, 50.9 %) as a tan solid.

Sources & evidence

ORD record
ord-d3fce1c8e3204b57a80e5c0d53c5c1f7
Source dataset
750 AstraZeneca ELN dataset
Original link
View source

Linked notes

Loading…